Jay H. Kalin
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
Papers in
-
- Histone Deacetylase Inhibitors Research 14
- Protein Degradation and Inhibitors 5
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 3
- Cancer therapeutics and mechanisms 3
- Signaling Pathways in Disease 3
- Oncology 12
- Peptidase Inhibition and Analysis 9
- Co-authors
- Alan P. Kozikowski (10 shared papers)Kyle V. Butler (3 shared papers)Giulio Vistoli (3 shared papers)Camille Brochier (1 shared paper)Brett Langley (1 shared paper)Joel Bergman (3 shared papers)Philip A. Cole (13 shared papers)Wayne W. Hancock (5 shared papers)
- Journals
- Journal of the American Chemical Society (4 papers)Journal of Medicinal Chemistry (3 papers)PLoS ONE (2 papers)Journal of Clinical Investigation (2 papers)The FASEB Journal (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Jay H. Kalin
28 papers receiving 1.7k citations
Jay H. Kalin's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 611
- Molecular Biology 1.4k
- Organic Chemistry 272
- Physiology 40
- Pharmacology 117
Countries citing papers authored by Jay H. Kalin
This map shows the geographic impact of Jay H. Kalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Kalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Kalin more than expected).
Fields of papers citing papers by Jay H. Kalin
This network shows the impact of papers produced by Jay H. Kalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Kalin. The network helps show where Jay H. Kalin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay H. Kalin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A Hit paper breakdown → | 2010 | 628 |
| 2 | 2012 | 145 | |
| 3 | 2014 | 116 | |
| 4 | 2013 | 113 | |
| 5 | 2011 | 92 | |
| 6 | 2014 | 83 | |
| 7 | 2012 | 81 | |
| 8 | 2015 | 64 | |
| 9 | 2018 | 51 | |
| 10 | 2020 | 48 | |
| 11 | 2018 | 44 | |
| 12 | 2006 | 42 | |
| 13 | 2019 | 36 | |
| 14 | 2012 | 31 | |
| 15 | 2009 | 17 | |
| 16 | 1955 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2014 | 16 | |
| 19 | 2015 | 13 | |
| 20 | 2019 | 12 |
About Jay H. Kalin
Jay H. Kalin is a scholar working on Molecular Biology, Oncology, Physiology, Immunology and Organic Chemistry, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (14 papers), Peptidase Inhibition and Analysis (9 papers), Protein Degradation and Inhibitors (5 papers), Epigenetics and DNA Methylation (5 papers), Ubiquitin and proteasome pathways (3 papers), Adenosine and Purinergic Signaling (3 papers), Cancer therapeutics and mechanisms (3 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Oncology (611 citations), Molecular Biology (1.4k citations), Organic Chemistry (272 citations), Physiology (40 citations) and Pharmacology (117 citations). Jay H. Kalin has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Alan P. Kozikowski, Kyle V. Butler, Giulio Vistoli, Camille Brochier, Brett Langley, Joel Bergman, Philip A. Cole, Wayne W. Hancock, Brian Budke and Philip P. Connell. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry, PLoS ONE, Journal of Clinical Investigation and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.